Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of AgeJames Wild, M. Hale, Lynn R. Webster et al.|Drugs & Aging|2020Cited by 20
Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 StudiesMichael Camilleri, James Wild, Lynn R. Webster et al.|Journal of Pain Research|2021Cited by 14
Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced ConstipationJan Tack, James Wild, Michael Camilleri et al.|Clinical Gastroenterology and Hepatology|2021Cited by 12
<p>A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy</p>Lynn R. Webster, James Wild, Tadaaki Yamada et al.|Journal of Pain Research|2020Cited by 10